Labratfinder.com launches the COVID-19 web research info center as "Who is Who, Where is Who, and Who Uses What Products" free to access web page
ncarol.com/10054021

SILVERADO, Calif. - ncarol.com -- Labratfinder.com is a novel artificial intelligence based system for discovering the true end users of scientific products, key opinion leaders and prospecting collaborators. This free resource is aimed to help researches and other parties of interest across the globe involved in COVID-19 research to find the latest published information and identify potential collaborators, research products, and appropriate research techniques.

Their "Who Is Who, Where is Who and Who uses What in a World of COVID-19" resource page is based on the Artificial Intelligence analysis of millions of published peer-reviewed publications for a specific combination of keywords. On this page, one can see:

More on ncarol.com

• Victor Archibong Expands ItsArchiDuh Creator Brand
• ACHC International Hospital Standards Earn ISQua EEA Accreditation
• Parade of Homes Winners Announced
• ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
• Revinate launches hospitality's first data activation platform

• Organizations and scientists involved on an interactive map;
• Browse through the list or researchers with contact info and all relevant publications;
• Find out which major brands of life science research products are used in COVID-19 research; and how they are used by reading the references;
• And find how a particular research or laboratory / analytical techniques was used in the COVID-19 research.

The results are provided in an easy to search, exportable tables, ranked by: dates; number of publications; number of citations; and in a graphical interactive form representing the geographic distribution of information in a map based infographics.

This free, daily updated "Who is Who, Where is Who and Who Uses What in a World of COVID-19 Research page" can be readily accessed by clicking on this web page link: http://www.labratfinder.com/covid-19.